Starting Dose for Ropinirole
For Restless Legs Syndrome (RLS), start ropinirole at 0.25 mg orally once daily, taken 1-3 hours before bedtime. 1, 2
Dosing Algorithm by Indication
Restless Legs Syndrome (Primary Indication for Low-Dose Initiation)
Initial dosing:
- Start with 0.25 mg once daily, 1-3 hours before bedtime 1, 2
- After 2 days, increase to 0.5 mg if needed 1, 2
- At end of Week 1, increase to 1 mg if needed 2
Titration schedule:
- Week 2: 1 mg 2
- Week 3: 1.5 mg 2
- Week 4: 2 mg 2
- Continue weekly 0.5 mg increments up to maximum 4 mg at Week 7 if needed 1, 2
The American Geriatrics Society recommends this gradual titration approach, though it's important to note that the American Academy of Sleep Medicine suggests against standard use of ropinirole for RLS due to long-term adverse effects, particularly augmentation. 1, 3 If used, it should be reserved for patients prioritizing short-term symptom reduction over long-term safety concerns. 1, 3
Parkinson's Disease
Initial dosing:
- Start with 0.25 mg three times daily (total daily dose 0.75 mg) 2
- Week 2: 0.5 mg three times daily (1.5 mg total) 2
- Week 3: 0.75 mg three times daily (2.25 mg total) 2
- Week 4: 1 mg three times daily (3 mg total) 2
Further titration:
- After Week 4, increase by 1.5 mg/day weekly up to 9 mg/day 2
- Then increase by up to 3 mg/day weekly to maximum 24 mg/day (8 mg three times daily) 2
Special Population Adjustments
Renal Impairment
Moderate renal impairment (CrCl 30-50 mL/min):
- No dose adjustment necessary 2
End-stage renal disease on hemodialysis:
- RLS: Start 0.25 mg once daily; maximum 3 mg/day 2
- Parkinson's: Start 0.25 mg three times daily; maximum 18 mg/day 2
- Supplemental doses after dialysis are not required 2
Elderly Patients
Critical monitoring considerations:
- Older patients face particular risk for orthostatic hypotension and drug interactions 1
- Hallucinations occur more commonly in elderly patients 1
- Cognitive effects may be more pronounced 1
- Start at the standard low dose but monitor closely for these adverse effects 1
Key Safety Monitoring
Monitor from initiation:
- Orthostatic hypotension, especially when initiating or increasing dose 1
- Gastrointestinal effects (nausea, vomiting) - most common side effects 1
- CNS effects including somnolence, drowsiness, headache 1
- Compulsive behaviors (gambling, hypersexuality, shopping, eating) 1
Common pitfall to avoid: The augmentation phenomenon in RLS patients is characterized by worsening and earlier onset of symptoms despite initial control. 1, 3 This typically presents as earlier symptom onset during the day, increased intensity, and spread to other body parts. 1 This risk underscores why the American Academy of Sleep Medicine recommends against standard use for RLS. 1, 3
Discontinuation Protocol
When stopping ropinirole: